A new slate of mass tort cases is gathering momentum in Philadelphia’s Complex Litigation Center as the matters that dominated its docket in recent years approach resolution. The two largest matters in the program—one of the country’s busiest hubs for mass tort litigation—are in various stages of winding down, and in recent months three new mass tort cases have emerged.

The vena cava and Risperdal litigation remain the largest two programs in the Complex Litigation Center, according to case listings on the court’s website. But Feldman & Pinto’s Rosemary Pinto, who serves as plaintiffs counsel in both matters, says parties are working to resolve the remaining cases in both programs.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]